Trabectedin as a Treatment Option for Patients with Ovarian Cancer

Bradley Monk, MD

Special Reports, Gynecologic Cancers (Issue 1), Volume 1, Issue 1

Bradley Monk, MD, gynecologic oncologist, University of Arizona Cancer Center Phoenix Branch, discusses trabectedin as a potential agent to treat ovarian cancer.

Bradley Monk, MD, gynecologic oncologist, University of Arizona Cancer Center Phoenix Branch, discusses trabectedin as a potential agent to treat ovarian cancer.

Read about research into ovarian cancer > >